OXURION (EBR:OXUR) | Finanzwire

PRESS RELEASE

published on 03/16/2026 at 18:00, 1 month 23 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 bonds in Oxurion, resulting in EUR 100,000 capital increase. Oxurion issues 18.59M new shares as part of a EUR 20M Capital Commitment agreement with Atlas

Convertible Bonds Capital Increase Share Issuance Atlas Special Opportunities Oxurion
BRIEF

published on 03/10/2026 at 18:35, 1 month 29 days ago

Oxurion extends its financing program until 2027

Convertible Bonds Funding Extension Market Capitalization Oxurion
BRIEF

published on 03/10/2026 at 18:35, 1 month 29 days ago

Oxurion Extends Financing Program with Atlas Special Opportunities

Convertible Bonds Market Capitalization Oxurion Financing Atlas Agreement Bond Maturity
PRESS RELEASE

published on 03/10/2026 at 18:30, 1 month 29 days ago

Oxurion Extends Its Financing Program
Oxurion NV extends financing program with Atlas Special Opportunities II, LLC. Amendments include 12-month extension, adjusted maturity terms, and right to transfer bonds internationally

Biopharmaceutical Company Oxurion NV Financing Program Atlas Special Opportunities II LLC Bond Subscription Agreement
BRIEF

published on 02/27/2026 at 18:05, 2 months 9 days ago

Oxurion continues discussions for the acquisition of a French CRO

Acquisition Pharmaceutical Due Diligence Oxurion French CRO
BRIEF

published on 02/27/2026 at 18:05, 2 months 9 days ago

Oxurion Extends Negotiations for French CRO Acquisition

Acquisition Biopharmaceutical Due Diligence Oxurion French CRO
PRESS RELEASE

published on 02/27/2026 at 18:00, 2 months 9 days ago

Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO
Oxurion NV extends negotiations for acquiring majority stake in French CRO. Due diligence process ongoing to confirm business plan. Company aims to inform market of further developments

Acquisition Due Diligence Negotiations Oxurion NV French CRO
BRIEF

published on 02/25/2026 at 18:05, 2 months 11 days ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Transparency Notification Atlas Special Opportunities Oxurion Digital Investments Shares In Circulation
BRIEF

published on 02/25/2026 at 18:05, 2 months 11 days ago

Oxurion Acknowledges Transparency Notification from Atlas Special Opportunities II LLC

Transparency Shareholding Atlas Special Opportunities Pharmaceutical Sector Oxurion
PRESS RELEASE

published on 02/25/2026 at 18:00, 2 months 11 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV in Leuven received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in shareholding. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation Pharmaceutical Subcontractors

Published on 05/09/2026 at 01:55, 11 hours 46 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 12 hours 1 minute ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 12 hours 11 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 13 hours 41 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 14 hours 40 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 17 hours 3 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 18 hours 29 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 18 hours 39 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 19 hours 12 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:21, 19 hours 20 minutes ago

Bond Issue

View all EQS

Published on 05/07/2026 at 19:15, 1 day 18 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 18 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 19 hours ago

DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:12, 1 day 19 hours ago

LNA SANTE : Q1 2026
Published on 05/07/2026 at 17:45, 1 day 19 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

News